Case File
efta-efta01759855DOJ Data Set 10CorrespondenceEFTA Document EFTA01759855
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01759855
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Kirschner, Elyse
Sent:
Friday, April 26, 2013 6:17 PM
To:
Jeffrey Epstein
Subject:
RE: Re:
We drafte= the partnership agreement, but Akin Gump was heavily involved as well.&nb=p; They prepared that transfer
instrument I just sent you.
Interestingly, AIF IV Management, Inc. was added as a=partner at the last minute. The unsigned Word version of the
partner=hip agreement I have on my firm's network does not have AIF IV Management =isted as a partner. But the
signed copy does.
I tried to reach out to Wendy Dulman, who was at Akin Gump a= the time this partnership was formed, to see if she has
any recollection =f this issue with AIF IV Management. She said she didn't remember.
If AIF IV Management had an economic interest =n the underlying fund at the time the partnership was created, it may
have=been decided to add AIF IV as a partner at the last minute to avoid sectio= 2701 concerns. That's why I want to
see a copy of the partnership a=reement of Apollo IV Management LP. Ada and Eileen are trying to loc=te it for me.
=/o:p>
Elyse G. Kirschner = Partner
McDermott Will & Emery LLP I 340 Madison Avenue, Ne= York, NY 10173
+www.mwe.com
From: </=pan>
Sent: Friday, A=ril 26, 2013 2:07 PM
To: Kirschner, Elyse
Subject: Re:=Re:
<=iv>
did it have value„ a capital account =tc,
did you set up the partnership?
&=bsp;
On Fri, Apr 26, 2013 at 2:03 PM, K=rschner, Elyse «mailto
> wrote:
EFTA_R1_00063851
EFTA01759855
I =on't think that the 1988 trusts were grantor trusts.
=p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt=auto'>
Elyse G. Kirschner I Partner
McDermott Will & Emery LLP I 340 Madison=Avenue, New York, NY 10173
+<mailto:
<=span>www.mwe.com</=>
+<http://www.mwe.com>
=p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt=auto'> Jeffrey Epstein
[mailto:[email protected] <mailto:[email protected]>
Sent: Friday, Apri= 26, 2013 2:01 PM
To: Kirschner, Elyse
Subject: Re:
Am i corre=t to think that all other partners would be lean for income tax purposes a=d therefore not a true
partnership?
On Fri, Apr 26, 2013 at 1:56 PM Kirschner, Elyse <=a href="mailto
target="_blank'
<=a» wrote:
I don't recall that be=ng the reason.
I found the attached document (page A-3). It=shows that AIF IV Management, Inc. transferred an interest in Apollo
Manag=ment IV, LP to BFP when BFP was formed. I've asked Ada to see a copy=of the LP agreement for Apollo
Management IV. We'd like to see who t=e other partners of Apollo Management IV were.
=/o:p>
Elyse G. =irschner I Partner
McDermott Will & Emery LLP 1=340 Madison Avenue, New York, NY 10173
=pan
+style=lont-size:10.0pt;font-family:"Arial","sans-serif";colortlue1= I
+www.mwe.com<=span> <http://www.mwe.com>
<=iv style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0=n 0in'>
2
EFTA_R1_00063852
EFTA01759856
From: Jeffrey Epstein (mailto:[email protected] <mailto:jeevacation@gm=il.com>
Sent: Frid=y, April 26, 2013 1:28 PM
To: Kirschner, Elyse
Subject:
is it=possible that the only reason that ap iv ltd was added as an Ip. was to ma=e sure that all entities were not
disregarded for tax purposes, and =hat a partnership requires at least two entites,? ? even thoug= it is a sub s, for Ip
purposes i believe it qualfires as a non disregard=d entity, any memories?
r•rr
The information contained in this communication is confidential= may be attorney-client privileged, may constitute
inside information, =nd is intended only for the use of the addressee. It is the property of=br>Jeffrey Epstein
Unauthorized use, disclosure or copying of this =ommunication or any part thereof is strictly prohibited and may be
unla=ful. If you have received this communication in error, please notify us=immediately by return e-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy =his communication and all copies thereof,
including all attachments. co=yright -all rights reserved
IRS Circular 230 Disclosure: To comply with requirements imp=sed by the IRS, we inform you that any U.S. federal tax
advice contained h=rein (including any attachments), unless specifically stated otherwise, is=not intended or written to
be used, and cannot be used, for the purposes o= (i) avoiding penalties under the Internal Revenue Code or (ii)
promoting,=marketing or recommending to another party any transaction or matter herei=.
This message is a PRIVILEGED AND CONFIDENTIAL communicat=on. This message and all attachments are a private
communication sent by a=law firm and may be confidential or protected by privilege. If you are not=the intended
recipient, you are hereby notified that any disclosure, copyi=g, distribution or use of the information contained in or
attached to this=message is strictly prohibited. Please notify the sender of the delivery e=ror by replying to this message,
and then delete it from your system. Than= you.
Please visit http://www.mwe.com/ for m=re information about our Firm.
The information contained in this communication is con=idential, may be attorney-client privileged, may constitute
inside info=mation, and is intended only for the use of the addressee. It is the pr=perty of Jeffrey Epstein Unauthorized
use, disclosure or copying of=this communication or any part thereof is strictly prohibited and ma= be unlawful. If you
have received this communication in error, please =otify us immediately by return e-mail or by e-mail to
[email protected], and
3
EFTA_R1_00063853
EFTA01759857
including all attach=ents. copyright -all rights reserved
The information contained in this =ommunication is confidential, may be attorney-client privileged, may
the use of the =ddressee. It is the property of Jeffrey Epstein Unauthorized use, d=sclosure or copying of this
communication or any part thereof is strict=y prohibited and may be unlawful. If you have received this communic=tion
in error, please notify us immediately by return e-mail or by e-ma=l to [email protected]
<mailto:[email protected]> , and destroy this communication and all copies thereof,<=r>including all attachments.
copyright -all rights reserved
=/div>
4
EFTA_R1_00063854
EFTA01759858
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.